Unique ID issued by UMIN | UMIN000055078 |
---|---|
Receipt number | R000062565 |
Scientific Title | Evaluation of the Effects of Test Food Consumption on Performance |
Date of disclosure of the study information | 2025/07/26 |
Last modified on | 2025/03/24 19:58:56 |
Evaluation of the Effects of Test Food Consumption on Performance
Evaluation of the Effects of Test Food Consumption on Performance
Evaluation of the Effects of Test Food Consumption on Performance
Evaluation of the Effects of Test Food Consumption on Performance
Japan |
Male/female adults
Adult |
Others
NO
To scientifically evaluate the effects of test food consumption on performance in study subjects aged 25 to 49 years who have poor sleep quality and persistent physical fatigue.
Safety,Efficacy
Subjective Mood Questionnaire
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Consumption of the test food (3 tablets a day) for 8 weeks
Consumption of the placebo food (3 tablets a day) for 8 weeks
25 | years-old | <= |
49 | years-old | >= |
Male and Female
1. Men and women aged 25 to 49 years at the time of consent.
2. Subjects who have a habit of exercising for more than 5 hours per week.
3. Subjects who have perceived poor sleep quality for more than one month prior to consent acquisition.
4. Subjects who have perceived physical fatigue for more than one month prior to consent acquisition.
5. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.
1. Subjects currently undergoing medication or outpatient treatment for any serious disease, or those with a history of serious disease.
2. Subjects who cannot maintain their exercise habits and dietary habits from before the study during the trial period.
3. Subjects who are prone to diarrhea or have a weak stomach when consuming dairy products or foods containing lactic acid bacteria in excess.
4. Subjects with extremely irregular lifestyle habits, such as diet and sleep.
5. Subjects who are participating in the other clinical trials and/or who have participated in the other clinical trials within 4 weeks prior to the current trial and/or who are planning to participate in the other clinical trials.
6. Females who are pregnant or lactating, and females who could become pregnant during trial period.
7. Subjects with allergies to medications and/or food.
8. Subjects deemed unsuitable for participation in the trial by the study representative or the principal investigator.
50
1st name | Fumiko |
Middle name | |
Last name | Nakamura |
CPCC Company Limited
Clinical Support Department
103-0021
4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo, Japan
03-6225-9001
cpcc-contact@cpcc.co.jp
1st name | Masanori |
Middle name | |
Last name | Numa |
CPCC Company Limited
Clinical Planning Department
103-0021
4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo, Japan
03-6225-9001
cpcc-contact@cpcc.co.jp
CPCC Company Limited
Asahi Quality & Innovations, Ltd.
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan
03-6225-9005
IRB@cpcc.co.jp
NO
2025 | Year | 07 | Month | 26 | Day |
Unpublished
Completed
2024 | Year | 06 | Month | 24 | Day |
2024 | Year | 06 | Month | 21 | Day |
2024 | Year | 07 | Month | 28 | Day |
2024 | Year | 11 | Month | 25 | Day |
2024 | Year | 07 | Month | 26 | Day |
2025 | Year | 03 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062565